Clinical Study Results
Research Sponsor: Pearl Therapeutics, Inc.
Medicines Studied: Budesonide and formoterol fumarate
Study Title: A study to learn how different treatments of budesonide
and formoterol fumarate affect the lung function of
participants with moderate to very severe COPD
Thank you!
Thank you to the participants who took part in this clinical study for the study
medicines budesonide and formoterol fumarate. You and all of the participants
helped researchers learn more about treatments of budesonide and formoterol
fumarate taken together to help people with moderate to very severe chronic
obstructive pulmonary disease, also known as COPD.
Pearl Therapeutics, Inc. sponsored this study and thinks it is important to share the
results of this study with you and the public. An independent non-profit organization
called CISCRP helped prepare this summary of the study results for you. We hope
it helps you understand and feel proud of your important role in medical research.
If you participated in this study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with this study now?
Each participant was in this study for about 7 months. But, the entire study took
about 1.5 years to complete.
This study started in June 2016 and ended in November 2017. This study included
2,389 participants in Canada, the Czech Republic, Germany, Hungary, Poland,
Russia, and the United States.
The sponsor reviewed the data collected when this study ended and created a
report of the results. This is a summary of that report.
1